Primary Record
Losmapimod
- In stock
- 2,011 g
- Purity
- 99.3 %
- CAS
- 585543-15-3
Compound Identifiers & Properties
- CAS
- 585543-15-3
- PubChem CID
- 11552706
- SMILES
- CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C
- Canonical SMILES
- Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
Names & Synonyms
- Losmapimod
- 585543-15-3
- GSK-AHAB
- losmapimodum
- GSKAHAB
- Losmapimod?
- GW856553X
- GW856553
- Losmapimod (GW856553X)
- F2DQF16BXE
- Losmapimod [USAN:INN]
- UNII-F2DQF16BXE
- LOSMAPIMOD [INN]
- FTX1821
- Losmapimod (USAN/INN)
- RefChem:800053
- LOSMAPIMOD [USAN]
- Losmapimod,gw-856553
- C22H26FN3O2
- D0C8DD
- LOSMAPIMOD [WHO-DD]
- MFCD16619322
- FTX-1821
- GW-856553X
- DTXSID30974109
- GTPL7835
- GW-856553
- orb1305817
- SCHEMBL1070401
- CHEMBL1088752
- GW 856553X
- SCHEMBL29367949
- SCHEMBL29888732
- EX-A486
- CHEBI:131167
- KKYABQBFGDZVNQ-UHFFFAOYSA-N
- DTXCID701401545
- GLXC-90276
- HMS3653G19
- HMS3673K13
- losmapimod pound>>GW-856553
- AOB87105
- BCP09909
- FTX 1821
- SB 856553
- 2523AH
- BDBM50418610
- NSC785336
- NSC800785
- s7215
- ZINC35793138
- AKOS015994587
- 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
- CCG-268442
- CS-3235
- DB12270
- GE-0056
- GW 856553
- NSC-785336
- NSC-800785
- SB16761
- CID11552706
- GSK-AHAB;GW856553X;SB856553
- NCGC00386332-03
- NCGC00481552-01
- AC-35781
- AK547876
- AN-27884
- BC600588
- CID:11552706
- DA-33431
- GS856553
- HY-10402
- SB856553
- SY358295
- 6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-neopentylnicotinamide
- SID:196409639
- B4620
- FT-0700337
- NS00072158
- SW219307-1
- A12526
- D09639
- 543C153
- A857749
- C543534
- Q6683687
- BRD-K56195681-001-01-0
- B0084-094991
- 6-(5-((CYCLOPROPYLAMINO)CARBONYL)-3-FLUORO-2-METHYLPHENYL)-N-(2,2-DIMETHYLPROPYL)-3-PYRIDINECARBOXAMIDE
- 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methyl-phenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
- 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide
- 3-PYRIDINECARBOXAMIDE, 6-(5-((CYCLOPROPYLAMINO)CARBONYL)-3-FLUORO-2-METHYLPHENYL)-N-(2,2-DIMETHYLPROPYL)-
- 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide.
- 6-(5-cyclopropylcarbamoyl-3-fluoro-2-methyl-phenyl)-N-(2,2-dimethylpropyl)-nicotinamide
- 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-neopentylnicotinamide
- GSK-AHAB;GW856553X;SB856553;GW 856553X;SB 856553;GW-856553X;SB-856553
- 3-pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-
- 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide
- 6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
- 6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide
- 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide
- GSK-AHAB|||GW-856553X|||6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide